Boehringer Ingelheim (Canada) Ltd.
Registration:
1
of
2
(2023-05-18
to
2024-06-11)
Policies or Program
- Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
- Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).